Safety and TDM of Continuous Infusion Vancomycin Through Continuous Renal Replacement Therapy Solution

Status unconfirmed · Phase 1

Conditions studied: Pediatric Continuous Renal Replacement Therapy, Dialysis, Renal Failure

In brief

The purpose of this investigation is to evaluate the safety of delivering continuous infusion (CI) vancomycin in pediatric CRRT by utilizing CI via by mixing the vancomycin into the CRRT solution(s). The secondary objectives are to describe the ability to achieve therapeutic vancomycin concentrations by utilizing this new delivery technique. Primary Objectives: To determine whether delivering continuous infusion vancomycin mixed into the CRRT solution can maintain therapeutic levels of drug in patients being treated for proven or suspected Gram-positive bacterial infections.

Key facts

Study ID

NCT02663596

Run by

Drexel University

People needed

10

Starts

2017-01-01

Expected to finish

2022-12-01

Last updated by the study team

2020-10-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients eligible to participate in the study must meet all of the following criteria prior to any study-related procedure:
• The need for continuous renal replacement therapy (CRRT) of any modality
• CVVH-continuous veno-venous hemofiltration
• CVVHD-continuous veno-venous hemodialysis
• CVVHDF-continuous veno-venous hemodiafiltration
• Documented or suspected Gram-positive bacterial infection necessitating the use of vancomycin while receiving CRRT.

You may not qualify if…

• Patients will be considered ineligible if they meet any of the following criteria:
• History of any moderate or severe hypersensitivity or allergic reaction to vancomcyin (a history of mild rash followed by uneventful re-exposure and/or red man syndrome is not a contraindication)
• Any rapidly-progressing disease or immediately life-threatening illness (defined as imminent death within 48 hours in the opinion of the investigator)
• Any condition or circumstance that, in the opinion of the investigator, would compromise the safety of the patient or the quality of study data
• Planned or prior participation in any other interventional drug study within 30 days
• Females that are pregnant or breastfeeding

Where it is running

• St. Christopher's Hospital for Children — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.